A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

Clinical trial NCT01793636 · TERMINATED

Trial details

NCT number: NCT01793636
Sponsor: Queen Mary University of London
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Clear Cell Renal Carcinoma

Start date: 2013-02-01
Primary completion: 2014-05-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.